Frontier IP Group - CRIL wins EUR140,000 EU Graphene Flagship funding
Portfolio news - Cambridge Raman Imaging wins €140,000 EU Graphene Flagship funding
The Company, a spin out from the
Cambridge Raman Imaging is initially developing a Raman-imaging scanning microscope to diagnose and track tumors, and for other detection applications.
The technology uses graphene to modulate ultra-short pulses of light that can be synchronised in time and are much lower cost than conventional systems.
The Company's scanning microscope will target real-time digital images of fresh tissue samples to detect and show the extent of tumours, their response to drug treatments and to allow surgeons to see if a cancer has been completely removed.
Existing histopathology technologies mean samples taken from a patient must be stained and sent to a laboratory for analysis, including during operations. Cambridge Raman Imaging's lasers will be compact enough to use in an operating theatre, speeding up progress. The global market size for tumour analysis and tracking has been estimated to be
Potential future applications include endoscopic examination, scanning body fluids for pathogens or tumour cells, and imaging semiconductors or proteins.
The Graphene Flagship is one of the largest research initiatives ever funded by the EU, tasked with bringing together academic and industrial researchers to take graphene from academia and into society.
| || |
T: 020 7332 2338
| || |
| || |
M: 07464 546 025
Group website: www.frontierip.co.uk
| || |
T: 0203 328 5656
| || |
ABout frontier IP
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
ABOUT THE GRAPHENE FLAGSHIP
The Graphene Flagship is research, innovation and collaboration.
Funded by the
About RNS Reach announcements
This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.
This information is provided by RNS, the news service of the
Quick facts: Frontier IP Group PLC
Market Cap: £33.2 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE